Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Baybio Panel: The New Norms of HR [7 April 2010]

TriNet was invited to host a panel on some of these HR challenges during the conference, and we were excited to facilitate a great discussion between CEOs with growing companies and the 20-25 attendees in the session. We talked about the “New Norms” in HR including growing healthcare and benefits costs, attracting top talent, and the implications of mergers and acquisitions.

See a video excerpt from our panel at http://www.youtube.com/watch?v=dIqB9MacLos

  • Be the first to comment

  • Be the first to like this

Baybio Panel: The New Norms of HR [7 April 2010]

  1. 1. Human Resources Strategies: Defining the New Norms<br />April 7, 2010<br />3:50 – 5:05 PM<br />
  2. 2. Panelists<br />Bruce Cohen President and CEO, VitaPath Genetics<br />Steven R. Deitcher, M.D. President, CEO and Board Member, HanaBiosciences, Inc.<br />Elisa Yu Vice President Operations, CPC Scientific<br />Jack Midgley Vice President Products, TriNet<br />
  3. 3. The “New Normal” ?<br />Escalating Costs of Healthcare Benefits<br />What will healthcare reform really mean for the industry?<br />How shall bio companies respond to escalating costs?<br />Increased Mergers & Acquisitions <br />What does this mean for employees and management?<br />How shall we set expectations and manage outcomes?<br />Challenges Around Hiring & Retention<br />How shall we attract and retain the right scientific, technical and business talent? <br />Increased Outsourcing of “Non-Core” Functions <br />What stays – and what goes?<br />
  4. 4. Escalating Healthcare Costs<br />Employer Responses:<br /><ul><li>Plan Design Changes
  5. 5. Wait Periods
  6. 6. Increasing Employee Share
  7. 7. Adoption of HDHP vs PPO
  8. 8. Differential Funding
  9. 9. After 2014:
  10. 10. Pay the Fine?
  11. 11. Encourage Employees to Buy Through Exchanges?
  12. 12. Changes in Perceived Value of Employer-Sponsored Plans?</li></ul>Average Annual Health Insurance Premiums and Worker Contributions for Family Coverage<br />1999 -2009<br />$13,375<br />132% Employer Cost Increase<br />$5,791<br />Source: http://ehbs.kff.org/pdf/2009/7936.pdf<br />
  13. 13. Increased Mergers and Acquisitions<br /><ul><li>1,171 total deals; $295B committed
  14. 14. 2009 had highest deal volume (193) and 2d highest deal value ($47B) since 2000
  15. 15. 18% of biotech targets had disclosed revenues at time of announcement
  16. 16. Four companies announced multiple acquisitions :
  17. 17. GSK(4)
  18. 18. Amgen (2)
  19. 19. Lilly (2)
  20. 20. Genzyme (2)</li></ul>Biotechnology Mergers and Acquisitions 2000 – 2009<br />Number of Deals by Year<br />2000 - 2009<br />Source: Leading Biotechnology Mergers and Acquisitions for the 10-Year Period Ended December 31, 2009 Revealed by DealSearchOnline.com; 31 March 2010<br />
  21. 21. Smaller, High-Wage Companies Are Hiring More Slowly<br /><ul><li>Are biotech companies accelerating hiring?
  22. 22. What challenges surround scientific, technical and business hiring?</li></ul>US Hiring Index<br />105<br />-2Since January<br />TriNet Hiring Index<br />93<br />-7Since January<br />
  23. 23. Panel Discussion<br />Escalating Costs of Healthcare Benefits<br /><ul><li>What will healthcare reform really mean for the industry?
  24. 24. How shall bio companies respond to escalating costs?</li></ul>Increased Mergers & Acquisitions <br /><ul><li>What does this mean for employees and management?
  25. 25. How shall we set expectations and manage outcomes?</li></ul>Challenges Around Hiring & Retention<br /><ul><li>How shall we attract and retain the right scientific, technical and business talent? </li></ul>Increased Outsourcing of “Non-Core” Functions <br /><ul><li>What stays – and what goes?</li>

×